Coverage Articles
- Principles of Study Design – 07.22.24
- Educational Article J1411 Hemgenix (esranacogene dezaparvovec-drlb) – 05.08.23
- Anesthesia for Pain Management Procedures
- Aprepitant for Chemotherapy Induced Emesis - MM8418
- Cardiac Rehabilitation: Coverage and Documentation Requirements
- Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) for Solid Tumors - MM8739
- Medicare National Coverage Determination (NCD) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease - MM8526
- MoPath: GeneSight® Assay for Refractory Depression Claims Submission Reminders
- National Coverage Determination (NCD) for Single Chamber and Dual Chamber Permanent Cardiac Pacemakers - MM8525
- NCD 110.24: Chimeric Antigen Receptor (CAR) T-Cell Therapy Billing Instructions
- Removal of Implantable Cardiac Devices
- Self-Administered Drug Exclusion List and Biologicals Excluded from Coverage - Medical Policy Article (A52527)
- SLEEP LAB CREDENTIALING: Polysomnography and Other Sleep Studies (L36902)
- Single Chamber and Dual Chamber Permanent Cardiac Pacemakers-Coding and Billing
Updated: 07.22.24